Nykode Therapeutics AS (VACBF)
OTCMKTS · Delayed Price · Currency is USD
0.3800
0.00 (0.00%)
At close: Feb 10, 2026
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of $133.03 million as of February 12, 2026. Its market cap has increased by 74.02% in one year.
Market Cap
133.03M
Enterprise Value
69.09M
Revenue
7.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.38
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 604.82M to 133.03M, a decrease of -78.00%. That is a compound annual growth rate of -22.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 133.03M | 69.51% |
| Dec 30, 2025 | 78.48M | -10.27% |
| Dec 30, 2024 | 87.46M | -87.31% |
| Dec 29, 2023 | 689.14M | -18.07% |
| Dec 30, 2022 | 841.13M | -68.30% |
| Dec 30, 2021 | 2.65B | 6.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 399.44M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| Vaxart | 141.56M |
| HST Global | 139.70M |
| BioStem Technologies | 92.40M |
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |